))
Why is Ketone Dosing so Important? - Jim Howard & Naomi Parrella: Ep 93
Manage episode 490441496 series 3673354
Content provided by Doug Reynolds and Pam Devine: Low Carb Podcasters. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Doug Reynolds and Pam Devine: Low Carb Podcasters or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
LowCarbUSA® Founder and CEO Doug Reynolds had a fascinating conversation about ketone dosing with BioSense Chief Medical Officer Naomi Parella, MD, and BioSense President and CEO Jim Howard.
…
continue reading
If you've ever been interested in easily measuring and tracking your level of nutritional ketosis over time, and in using these results to help you better manage your metabolic health and fat burning , you will be fascinated by Episode 93 of the LowCarbUSA® Podcast.
The Biosense® device measures breath acetone, which is produced as a byproduct of ketogenesis. The concentration of acetone in the breath indicates one's level of nutritional ketosis. The Biosense® system is intended for self-testing of acetone and is intended for home (lay user) or professional use in the management of patients seeking to reach or maintain nutritional ketosis.
Dr. Parrella is a family physician and obesity medicine specialist. She is a nationally recognized expert and frequently invited speaker, educator and strategist for universities, hospitals, communities, and businesses. An Associate Professor in both the Department of Family Medicine and the Department of Surgery, she is the Chief of Lifestyle Medicine, the Medical Director for Rush University’s Center for Weight Loss and Lifestyle Medicine, and the Director of Strategic Planning and Implementation within the Department of Surgery.
Jim Howard is a 27-year MedTech executive focused on value creation with novel approaches to patient care. He is passionate about behavioral changes in chronic diseases, putting healthcare in the hands of patients. Throughout his career, Jim has had great success scaling companies and attracting capital with disruptive digital health and software devices, including AR/VR, genomics, cardiovascular, and clinical decision support. He has used non-traditional strategies in the successful development of global health tech companies.
You can connect with BioSense on Twitter, Facebook, Instagram, or on their website.
100 episodes
Share
